Skip to main content
LIVG
OTC Technology

Livento Group Reports Q1 2026 Net Loss Amid Critically Low Cash, Revenue Decline, and Material MD&A Discrepancy

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.28
Mkt Cap
$40.392M
52W Low
$0.036
52W High
$3,080,000
Market data snapshot near publication time

summarizeSummary

Livento Group reported a net loss for Q1 2026 with critically low cash reserves and declining revenue, further complicated by a material misstatement in its Management's Discussion and Analysis.


check_boxKey Events

  • Reported Net Loss

    The company reported a net loss of $379,169 for Q1 2026, an improvement from a $677,540 loss in Q1 2025.

  • Critically Low Cash Balance

    Cash on hand stood at $15,738 as of March 31, 2026, down from $24,665 a year prior, indicating severe liquidity constraints.

  • Significant Revenue Decline

    Total revenue decreased significantly to $124,785 in Q1 2026 from $312,657 in Q1 2025.

  • Positive Operating Cash Flow

    Operating activities generated $114,087 in cash, a positive shift from a $9,012 outflow in the prior year, though insufficient to address overall liquidity.


auto_awesomeAnalysis

Livento Group's Q1 2026 filing reveals a precarious financial state, marked by a critically low cash balance of $15,738 and a significant year-over-year revenue decline. While the company reported a reduced net loss and positive operating cash flow, these improvements are overshadowed by severe liquidity constraints and the absence of financing activities this quarter. A major concern is a material discrepancy in the Management's Discussion and Analysis, which incorrectly states a net profit of $379,169, directly contradicting the reported net loss in the financial statements. This error raises serious questions about financial reporting accuracy and internal controls, adding significant risk for investors.

At the time of this filing, LIVG was trading at $0.28 on OTC in the Technology sector, with a market capitalization of approximately $40.4M. The 52-week trading range was $0.04 to $3,080,000.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed LIVG - Latest Insights

LIVG
May 15, 2026, 6:12 AM EDT
Filing Type: 10-Q
Importance Score:
9
LIVG
Feb 23, 2026, 6:17 PM EST
Filing Type: 8-K
Importance Score:
7